Patent Application
20220042979
This application claims priority from Chinese patent application No. 202010797874.X, filed on Aug. 10, 2020, the contents of which are incorporated by reference in their entirety.
The present disclosure relates to the technical field of analytical chemistry and disease diagnosis, and in particular to a biological nanoparticle detection method with high-sensitivity.
Exosomes are nano-sized cystic vesicles secreted by cells, which play an important role in cell-cell communication. In normal physiological and pathological conditions, almost all cells can secrete exosomes, but the number of exosomes secreted by cancerous cells is usually several orders of magnitude higher than that secreted by normal cells.
The size of exosomes ranges from about 30 nm to 150 nm. They comprise a variety of membrane proteins on the surface and nucleic acids, active enzymes and cytoplasmic substrates therein. Exosomes also comprise many proteins, and these proteins reflect the phenotype and physiological state of the cells, and are highly heterogeneous. The above-mentioned characteristics of exosomes can inform the relevant physiological states and pathological processes of many diseases, especially cancers. Therefore, the sensitive recognition of exosomes secreted by cells is of great significance for the biological research and clinical disease diagnosis.
Viruses are tiny life forms that can utilize nutrients in host cells and replicate their own life components such as nucleic acids and proteins. Viruses cause damage to human cells and tissues. For example, influenza viruses, HIV, and hepatitis viruses are common viruses. Most viruses are highly infectious. Effective and timely detection of the viruses and isolation of the source of infection to cut off the routes of infection are of great practical significance for arresting the spread of viruses and for the diagnosis and treatment of diseases.
Due to the small size of biological nanoparticles, for example, the size of viruses ranges from 60 nm to 140 nm, and the size of exosomes ranges from about 30 nm to 150 nm, they cannot be detected under ordinary optical microscopes. Fluorescence staining or flow cytometry is usually used to analyze and detect biological nanoparticles. However, the complicated fluorescence staining process and the weak light scattering of biological nanoparticles such as exosomes and viruses limit the use of these two methods in the detection of biological nanoparticles such as exosomes and viruses. Accordingly, in view of the above-mentioned technical problems, for nano-sized exosomes, viruses and other biological nanoparticles, visual analysis under a transmission electron microscope and nanoparticle tracking analysis are employed in the prior art. However, the transmission electron microscope and nanoparticle tracking analysis instrument are expensive, and the cost is about 500 RMB for each test of a biological sample such as exosomes and viruses. Moreover, before the biological nanoparticles such as exosomes and viruses are detected under a transmission electron microscope, they need to be stained; and the nanoparticle tracking analysis method requires a complicated separation and purification process.
To overcome the technical defects in the prior art of complicated pretreatment process before the detection of biological nanoparticles such as exosomes and viruses, expensive detection equipment and detection cost, as well as inability to distinguish interfering particles, an object of the present disclosure provides a simple, convenient and rapid biological nanoparticle detection method with high-sensitivity such as an exosome and a virus by specifically binding a labeling protein to the biological nanoparticle, to achieve the rapid and high-sensitivity detection of the biological nanoparticle such as an exosome and a virus.
To achieve the above objective, a biological nanoparticle detection method with high-sensitivity is provided in the present disclosure, which includes the following steps:
Step S1: reacting a copper compound nanoparticle with a surface membrane protein aptamer having a sulfhydryl group of the biological nanoparticle to obtain a copper compound-membrane protein aptamer conjugate;
Step S2: filtering a biological nanoparticle solution containing the biological nanoparticle through a first filter membrane, and adding the copper compound-membrane protein aptamer conjugate to the filtered solution, to obtain a biological nanoparticle-copper compound conjugate after reaction;
Step S3: adding a surfactant to the reaction solution obtained in Step S2, filtering through a second filter membrane, and washing the second filter membrane with PBS to obtain a third filter membrane containing the biological nanoparticle-copper compound conjugate; and
Step S4: adding a AgNO3 solution to the third filter membrane obtained in Step S3 and reacting; and then adding a mixed solution of triethylamine hydrochloride, hydrogen peroxide and 3,3′,5,5′-tetramethylbenzidine, reacting for development, and observing the color change of the filter membrane visually by naked eyes or by means of a camera.
Preferably, the biological nanoparticle is an exosome or a virus.
Preferably, in Step S1, the copper compound nanoparticle is one or more selected from a group consisting of: cupric sulfide, cupric oxide, cuprous oxide, and cuprous sulfide, the size of the copper compound nanoparticle is 5 to 50 nm, and the surface membrane protein aptamer having a sulfhydryl group is one or more selected from a groups consisting of: CD63 aptamer, CD81 aptamer, CD9 aptamer, EpCAM aptamer, HER2 aptamer, MUC1 aptamer, and PSMA aptamer; the reaction time of the copper compound nanoparticle with the surface membrane protein aptamer is 8 to 24 hrs; and the pore size of the first filter membrane is 200 nm.
Preferably, the reaction time of the biological nanoparticle solution with the copper compound-membrane protein aptamer conjugate in Step S2 is 0.5 to 10 hrs.
Preferably, a volume of the biological nanoparticle solution in Step S2 is adjustable, when the concentration of the biological nanoparticle solution is low, the volume of the biological nanoparticle solution is increased to improve the sensitivity.
Preferably, the surfactant in Step S3 is one or more selected from a group consisting of: sodium dodecyl sulfate, cetyltrimethylammonium bromide, and polyvinylpyrrolidone, and the concentration of the surfactant is in the range of 0.1 to 2.0%.
Preferably, the AgNO3 solution in Step S4 has a concentration of 10−5-10−3 M and a volume of 10 to 50 uL, the second filter membrane in Step S4 has a pore size in the range of 20 to 200 nm, and the reaction time of substance on a surface of the third filter membrane with the AgNO3 solution is in the range of 5 to 10 min, the concentration of triethylamine hydrochloride is 0.05 to 0.2 M, the concentration of hydrogen peroxide is 0.1 to 0.5 M, the concentration of 3,3′,5,5′-tetramethylbenzidine is 0.1 to 1.0 mM, and the reaction time is 5 to 30 min.
Compared with the prior art, the technical solution of the present disclosure has the following advantages:
The technical solution of the present disclosure is based on the highly specific antigen-antibody reaction and the high-efficiency catalytic reaction of copper-amine complexation, and can be used in the high-sensitivity detection of biological nanoparticles such as exosomes and viruses, by visual colorimetric method or by comparison with photos taken by a camera. In this way, high-sensitivity detection of an exosome solution having a concentration as low as 2.5×105counts/mL is easily achieved without the aid of any instruments.
Compared with the prior art, in the technical solution of the present disclosure, a labeling protein is specifically bound to a biological nanoparticle such as an exosome and a virus, and a copper compound-biological nanoparticle is enriched by filtering through a filter membrane, which can not only eliminate the interference from proteins and small molecules in an actual sample, but also achieve the rapid and high-sensitivity detection of the biological nanoparticle such as an exosome and s virus.
Moreover, the detection method according to the technical solution of the present disclosure has the advantages of low cost, high reaction efficiency, and excellent stability, and can be widely used in the detection of biological nanoparticles such as exosomes and viruses, and in the diagnosis of disease, especially cancer detection.
In order to more clearly explain the technical solutions in the embodiments of the present disclosure or in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below. Evidently, the drawings depicted below are merely some embodiments of the present disclosure, and those skilled in the art can obtain other drawings based on the structures shown in these drawings without any creative efforts.
The objects, functional characteristics and advantages of the present disclosure will be further described in combination with the embodiments and with reference to the accompanying drawings.
The technical solutions in the embodiments of the present disclosure will be described clearly and fully with reference to the accompanying drawings in the embodiments of the present disclosure. Apparently, the embodiments described are merely some, rather than all of the embodiments of the present disclosure. All other embodiments obtained by a person of ordinary skill in the art without creative efforts based on the embodiments of the present disclosure shall fall within the protection scope of the present disclosure.
It should be noted that if there are directional indications (such as on, below, left, right, front, back . . . ) involved in the embodiments of the present disclosure, these directional indications are only used to explain the relative positional relationship and movement of various components in a specific posture (as shown in the figures). If the specific posture changes, the directional indications will change accordingly.
In addition, if there are descriptions “first”, and “second”, etc. in the embodiments of the present disclosure, the descriptions “first” and “second” are used herein merely for the purposes of description, and are not intended to indicate or imply the relative importance or implicitly point out the number of the indicated technical feature. Therefore, the features defined by “first”, and “second” may explicitly or implicitly include at least one of the features. In addition, the technical solutions in various embodiments can be combined with each other, on the condition that the combinations can be accomplished by those of ordinary skill in the art. When a combination of technical solutions is contradictory or cannot be achieved, it is considered that such a combination of technical solutions does not exist, and does not fall within the protection scope of the present disclosure.
The present disclosure provides a method for high-sensitivity detection of an exosome.
In this example of the present disclosure, 1 mL of a CuS nanoparticle solution with a concentration of 1013 counts/mL was added to 20 uL of a solution of CD63 aptamer having a sulfhydryl group. Then, a 2 M sodium chloride solution was gradually added to give a final sodium chloride concentration of 0.1 M in the solution system. After 8 hrs of reaction, the reaction solution was centrifuged and washed to obtain CuS nanoparticles bearing CD63 aptamer.
20 uL of CuS nanoparticles bearing CD63 aptamer was added to 1 mL of an exosome solution with a concentration of 109 counts/mL and reacted for half an hour. Then 0.1% sodium dodecyl sulfate was added, and the solution was filtered through a filter membrane with a pore size of 50 nm and washed three times with PBS, to obtain a filter membrane containing exosomes-CuS. 10 uL of a AgNO3 solution having a concentration of 1.0×10−3 M was added to the filter membrane and reacted for 5 min.
A newly prepared 3,3′,5,5′-tetramethylbenzidine (TMB) solution and 5 uL of a newly prepared 10 mol/L hydrogen peroxide solution were added to 500 uL of a triethylamine hydrochloride solution, and mixed uniformly to prepare a detection solution.
The detection solution was added to the control group (a filter membrane obtained by performing the above experiment with a control solution without exosomes) and the filter membrane containing exosomes of 109 counts/mL. After standing for 5 min, the change in color between the filter membranes was observed and detected visually by naked eyes or by taking photos with a camera. The changes in color between the control group (the filter membrane obtained by performing the above experiment with the control solution without exosomes) and the filter membrane containing exosomes of 109 counts/mL is shown in
In this example of the present disclosure, 1 mL of a CuS nanoparticle solution with a concentration of 1013 counts/mL was added to 20 uL of a solution of CD63 aptamer having a sulfhydryl group. After 8 hrs of reaction, the reaction solution was centrifuged and washed to obtain CuS nanoparticles bearing CD63 aptamer.
20 uL of CuS nanoparticles bearing CD63 aptamer was added respectively to 1 mL of an exosome solution with a concentration of 1×107 counts/mL, 5×107 counts/mL, 1×108 counts/mL, 5×108 counts/mL, and 1.0×109 counts/mL and reacted for half an hour. Then 0.1% cetyltrimethyl ammonium bromide was added, and the solution was filtered through a filter membrane with a pore size of 50 nm and washed three times with PBS, to obtain a filter membrane containing exosomes-CuS. 10 uL of a AgNO3 solution having a concentration of 5.0×10−4 M was added to the filter membrane and reacted for 10 min.
A newly prepared 3,3′,5,5′-tetramethylbenzidine (TMB) solution and 5 uL of a newly prepared 10 mol/L hydrogen peroxide solution were added to 500 uL of a triethylamine hydrochloride solution, and mixed uniformly to prepare a detection solution.
The detection solution was added to the control group (a filter membrane obtained by performing the above experiment with a control solution without exosomes) and the filter membranes containing different concentrations of exosome (1×107 counts/mL, 5×107 counts/mL, 1×108 counts/mL, 5×108 counts/mL, and 1.0×109 counts/mL). After 5 min of reaction, the changes in color between the filter membranes was detected by visual colorimetric method or by taking photos with a camera. The change in color is shown in
In this example of the present disclosure, 50 mL of a CuS nanoparticle solution with a concentration of 1013 counts/mL was added to 1 mL of a solution of CD63 aptamer having a sulfhydryl group. After 8 hrs of reaction, the reaction solution was centrifuged and washed to obtain CuS nanoparticles bearing CD63 aptamer.
40 mL of CuS nanoparticles bearing CD63 aptamer was added to 200 mL of an exosome solution with a concentration of 1.0×107 counts/mL and reacted for half an hour. Then 0.3% sodium dodecyl sulfate was added, and the solution was filtered through a filter membrane with a pore size of 50 nm and washed three times with PBS, to obtain a filter membrane containing exosome-CuS. 10 uL of a AgNO3 solution having a concentration of 5.0×10−4 M was added to the filter membrane and reacted for 5 min.
A newly prepared 3,3′,5,5′-tetramethylbenzidine (TMB) solution and 5 uL of a newly prepared 10 mol/L hydrogen peroxide solution were added to 250 uL of a triethylamine hydrochloride solution, and mixed uniformly to prepare a detection solution.
The detection solution was added to the control group (a filter membrane obtained by performing the above experiment with a control solution without exosomes) and the filter membrane containing exosomes of 1.0×107 counts/mL. After 5 min of reaction, the change in color between the filter membranes was detected by visual colorimetric method or by taking photos with a camera. The changes in color are shown in
In this example of the present disclosure, 1 mL of a CuS nanoparticle solution with a concentration of 1013 counts/mL was added to 20 uL of a solution of CD63 aptamer having a sulfhydryl group. Then, a 2 M sodium chloride solution was gradually added to give a final sodium chloride concentration of 0.1 M in the solution system. After 8 hrs of reaction, the reaction solution was centrifuged and washed to obtain CuS nanoparticles bearing CD63 aptamer.
100 uL of CuS nanoparticles bearing CD63 aptamer was added to 5 mL of an exosome solution with a concentration of 107 counts/mL and reacted for half an hour. Then 0.5% sodium dodecyl sulfate was added, and the solution was filtered through a filter membrane with a pore size of 50 nm and washed three times with PBS, to obtain a filter membrane containing exosome-CuS. 10 uL of a AgNO3 solution having a concentration of 1.0×10−3 M was added to the filter membrane and reacted for 5 min.
A newly prepared 3,3′,5,5′-tetramethylbenzidine (TMB) solution and 10 uL of a newly prepared 10 mol/L hydrogen peroxide solution were added to 400 uL of a triethylamine hydrochloride solution, and mixed uniformly to prepare a detection solution.
The detection solution was added to the control group (a filter membrane obtained by performing the above experiment with a control solution without exosomes) and the filter membrane containing exosomes of 107 counts/mL. After standing for 5 min, the changes in color between the filter membranes in the control group and the experiment group was detected by visual colorimetric method or by taking photos with a camera.
In this example of the present disclosure, 0.01 g of sodium dodecyl sulfate (SDS) was added to 1.0 mL of a CuS solution, and then 30 uL of 100 uM Thiol-Virus Aptamer and 10 uL of 2.5 mM tris(2-carboxyethyl)phosphine (TCEP) were added and reacted for 30 min to obtain a mixed solution. A 2 M NaCl solution was gradually added to give a final NaCl concentration of 0.1 M in the mixed solution. After 12 hrs of reaction, excess Thiol-Virus Aptamer was removed by centrifugation and washing three times with PBS, to obtain CuS-DNA complex particles, which was made up to 1.0 mL with PBS and stored in a freezer at 4° C.
1.0 mL of a solution containing a certain concentration of highly pathogenic H5N1 avian influenza virus was added to 20 uL of the above-mentioned CuS-DNA solution. After mixing and reacting for 1 hr, 0.5% SDS was added, and the solution was passed through a filter membrane having a pore size of 60 nm to obtain a filter membrane containing virus-CuS complex particles. Then the filter membrane was taken out and 20 uL of 10−4 M AgNO3 was added and reacted for 5 min.
A newly prepared 3,3′,5,5′-tetramethylbenzidine (TMB) solution and 10 uL of a newly prepared 10 mol/L hydrogen peroxide solution were added to 400 uL of a triethylamine hydrochloride solution, and mixed uniformly to prepare a detection solution.
The detection solution was added to the control group (a filter membrane obtained by performing the above experiment with a control solution without viruses) and the filter membrane containing viruses of 107 counts/mL. After standing for 5 min, the changes in color between the filter membranes in the control group and the experiment group was detected by visual colorimetric method or by taking photos with a camera.
In this example of the present disclosure, 0.01 g of sodium dodecyl sulfate (SDS) was added to 1.0 mL of a CuS solution, and then 30 uL of 100 uM Thiol-Virus Aptamer and 10 uL of 2.5 mM tris(2-carboxyethyl)phosphine (TCEP) were added and reacted for 30 min to obtain a mixed solution. A 2 M NaCl solution was gradually added to give a final NaCl concentration of 0.1 M in the mixed solution. After 12 hrs of reaction, excess Thiol-Virus Aptamer was removed by centrifugation and washing three times with PBS, to obtain CuS-DNA complex particles, which was made up to 1.0 mL with PBS and stored in a freezer at 4° C.
1.0 mL of a solution containing a certain concentration of highly pathogenic H5N1 avian influenza virus was added to 20 uL of the above-mentioned CuS-DNA solution. After mixing and reacting for 1 hr, 0.5% SDS was added, and the solution was passed through a filter membrane having a pore size of 70 nm to obtain a filter membrane containing virus-CuS complex particles. Then the filter membrane was taken out and 20 uL of 10−4 M AgNO3 was added and reacted for 5 min.
A newly prepared 3,3′,5,5′-tetramethylbenzidine (TMB) solution and 10 uL of a newly prepared 10 mol/L hydrogen peroxide solution were added to 400 uL of a triethylamine hydrochloride solution, and mixed uniformly to prepare a detection solution.
The detection solution was added to the control group (a filter membrane obtained by performing the above experiment with a control solution without viruses) and the filter membrane containing exosomes of 108 counts/mL. After standing for 5 min, the changes in color between the filter membranes in the control group and the experiment group was detected by visual colorimetric method or by taking photos with a camera.
In this example of the present disclosure, 0.01 g of sodium dodecyl sulfate (SDS) was added to 1.0 mL of a CuS solution, and then 30 uL of 100 uM Thiol-Virus Aptamer and 10 uL of 2.5 mM tris(2-carboxyethyl)phosphine (TCEP) were added and reacted for 30 min to obtain a mixed solution. A 2 M NaCl solution was gradually added to give a final NaCl concentration of 0.1 M in the mixed solution. After 12 hrs of reaction, excess Thiol-Virus Aptamer was removed by centrifugation and washing three times with PBS, to obtain CuS-DNA complex particles, which was made up to 1.0 mL with PBS and stored in a freezer at 4° C.
1.0 mL of a solution containing a certain concentration of highly pathogenic H5N1 avian influenza virus was added to 20 uL of the above-mentioned CuS-DNA solution. After mixing and reacting for 1 hr, 1.0% SDS was added, and the solution was passed through a filter membrane having a pore size of 70 nm to obtain a filter membrane containing virus-CuS complex particles. Then the filter membrane was taken out and 20 uL of 10−4 M AgNO3 was added and reacted for 5 min.
A newly prepared 3,3′,5,5′-tetramethylbenzidine (TMB) solution and 10 uL of a newly prepared 20 mol/L hydrogen peroxide solution were added to 400 uL of a triethylamine hydrochloride solution, and mixed uniformly to prepare a detection solution.
The detection solution was added to the control group (a filter membrane obtained by performing the above experiment with a control solution without viruses) and the filter membrane containing viruses of 5*108 counts/mL. After standing for 5 min, the change in color between the filter membranes in the control group and the experiment group was detected by visual colorimetric method.
The preferred embodiments of the present disclosure have been described above, which, however, are not intended to limit the scope of the present disclosure. Equivalent structural transformations, directly/indirectly applied to other related technical fields, made on basis of the disclosure of the description and drawings of the present disclosure without departing from the concept of the present disclosure, are included in the scope of protection of the present disclosure.
| Number | Date | Country | Kind |
|---|---|---|---|
| 202010797874.X | Aug 2020 | CN | national |
